Molecular basis of myelodysplastic/myeloproliferative neoplasms.
about
Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaCytogenetic risk stratification in chronic myelomonocytic leukemia.Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsClinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Clinical overview of cutaneous features in hypereosinophilic syndrome.Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders.Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.Characteristics of the four subtypes of myelodysplastic/myeloproliferative neoplasms.TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study.Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia.De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics.The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
P2860
Q27851991-8B905DA8-D5D5-41A5-93AE-31A0333FA22FQ34612592-D261D9A6-70AE-4F27-820F-E470DEFCAC9DQ36936451-94C91901-7D85-4D02-8A35-13178D58A457Q37349392-E0062A03-E1EB-4B33-9DC6-F5267F4E2A9CQ37987470-694ACA0F-EB2A-4ACB-9593-0EB5657E69AFQ38248429-70F7F4B6-B1C6-4509-8342-860553E276B4Q39455159-DAED0719-2C72-4C19-9592-BB8D3A18D883Q40639096-492A2F96-3C27-45D5-BF4E-F7AFE8240A36Q41484770-4AF7D92C-8670-497A-BB3A-F6EBAFB82CFAQ42415908-684C0E90-5D63-48DA-92D6-5F398DFA72FFQ42638915-BDB25A51-B16E-433A-A049-4BCBD7C7BD97Q43057954-41B5F8B8-7AF5-4994-A0CD-96C62A3D225BQ43880033-AD7E1710-A858-42FA-A075-A63EA6EEBB52Q53128006-5F78EFE5-B269-4663-AAC2-A0A4D3A3FABBQ54512112-836E3EF8-FB8A-4F81-B4D6-0BEF5BC2EDBAQ55324702-1F18D420-C1C0-41BD-ACA9-4EEE6F5AC006Q57069030-B2B4D11A-9D54-40F7-8AB6-BB6D2609DFCD
P2860
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@en
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@nl
type
label
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@en
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@nl
prefLabel
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@en
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@nl
P2093
P2860
P1433
P1476
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
@en
P2093
Andreas Reiter
Mario Cazzola
Rosangela Invernizzi
P2860
P304
P356
10.3324/HAEMATOL.2009.014001
P577
2009-12-01T00:00:00Z